Microbot Medical is a pre-clinical medical device company engaged in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Co.'s technological platforms, ViRob, TipCAT and Liberty, are comprised of proprietary technologies. Using the ViRob platform, Co. is developing the Self Cleaning Shunt (SCS) for the treatment of hydrocephalus and Normal Pressure Hydrocephalus. Utilizing the Liberty and CardioSert platforms, Co. is developing the disposable robot for various endovascular interventional procedures. Co. is also focused on the development of a Multi Generation Pipeline Portfolio utilizing all of its technologies. The MBOT stock yearly return is shown above.
The yearly return on the MBOT stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2015 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the MBOT annual return calculation with any dividends reinvested as applicable (on ex-dates).
|